思连康联合头孢克肟治疗小儿细菌性肠炎30例疗效分析  

Efficacy analysis of Siliankang combined with cefixime in the treatment of 30 cases of pediatric bacterial enteritis

作　　者：叶晓丽 陈忠宁[1] 

机构地区：[1]深圳市宝安区松岗人民医院,518105

出　　处：《中国实用医药》2017年第31期97-99,共3页China Practical Medicine

摘　　要：目的研究双歧杆菌四联活菌片(商品名:思连康)联合头孢克肟治疗小儿细菌性肠炎的疗效。方法 60例细菌性肠炎患儿,随机分为对照组及观察组,各30例。对照组实施头孢克肟治疗,观察组实施思连康联合头孢克肟治疗。对比两组患儿的临床治疗效果、肠道菌群情况。结果观察组患儿的临床总有效率为93.33%,高于对照组的60.00%,差异具有统计学意义(P<0.05)。治疗前,两组患儿的肠道菌群情况比较,差异无统计学意义(P>0.05);治疗后,观察组患儿的肠道菌群情况优于对照组,差异具有统计学意义(P<0.05)。结论思连康联合头孢克肟能够使细菌性肠炎患儿的临床症状及肠道菌群情况得到明显的改善,临床效果确切,值得临床推广。Objective To study the efficacy of bifidobacterium quadruple viable tablets （trade name： Siliankang） combined with cefixime in the treatment of 30 cases of pediatric bacterial enteritis. Methods A total of 60 bacterial enteritis children were randomly divided into control group and observation group, with 30 cases in each group. The control group was treated with cefixime, and the observation group was treated with Siliankang combined with cefixime. Comparison were made on clinical treatment effect and intestinal microflora situation between two groups. Results The observation group had higher total clinical treatment effective rate as 93.33% than 60.00% in the control group, and the difference was statistically significant （P〈0.05）. Before treatment, both groups had no statistically significant difference in intestinal microflora situation （P〉0.05）. After treatment, the observation group had better intestinal microflora situation than the control group, and the difference was statistically significant （P〈0.05）. Conclusion Combination of Siliankang and cefixime can obviously improve the clinical symptoms and intestinal microflora situations in children with bacterial enteritis, and the clinical effect is affirmative It is worthy of clinical promotion.

关 键 词：小儿细菌性肠炎 双歧杆菌四联活菌片 头孢克肟 

分 类 号：R725.7[医药卫生—儿科]